Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Beleric Myrobalan (Terminalia bellirica) contains bioactive compounds including galloyl glucose, belleric acid, and chebulagic acid that exert anti-inflammatory effects by blocking pro-inflammatory enzyme active sites and suppressing NF-κB activation. The fruit demonstrates antibacterial activity at 30-500 μg/disc concentrations against multiple pathogenic bacteria species.
Reported Benefits (Provisional)
Origin & History
Beleric Myrobalan, *Terminalia bellirica*, is a deciduous tree native to the plains and lower hills of South and Southeast Asia, particularly India, Nepal, and Sri Lanka. Thriving in tropical and subtropical climates, its fruit is a cornerstone of traditional medicine. It is highly valued for its adaptogenic properties and rich phytochemical profile, making it significant for holistic wellness.
Research Narrative (Provisional)
Scientific research supports the traditional uses of *Terminalia bellirica*, highlighting its antioxidant, anti-inflammatory, and antimicrobial properties. Studies indicate its potential in promoting digestive regularity, enhancing respiratory function, and supporting cardiovascular health, aligning with its adaptogenic classification.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin C - Minerals: Potassium, Magnesium, Iron - Macronutrients: Dietary Fiber - Phytochemicals: Polyphenols (Gallic acid, Ellagic acid, Chebulinic acid), Flavonoids, Saponins, Lignans
Reported Mechanism (Provisional)
Beleric Myrobalan's flavonoids and gallic acid block active sites of pro-inflammatory enzymes that convert arachidonic acid into prostaglandins and leukotrienes, while simultaneously suppressing NF-κB transcription factor activation. The polyphenolic compounds including chebulagic acid and β-sitosterol are metabolized by gut microbiota into urolithins that prevent oxidative cellular damage. These mechanisms collectively produce immunomodulatory effects beyond direct anti-inflammatory action.
Clinical Narrative (Provisional)
Current evidence for Beleric Myrobalan relies primarily on in vitro studies rather than robust human clinical trials. Laboratory testing demonstrates antibacterial activity against gram-positive and gram-negative bacteria at concentrations of 30-500 μg/disc, including efficacy against Shigella, Proteus, Klebsiella, and Pseudomonas species. While traditional uses report antidiabetic, hepatoprotective, and cardiovascular benefits, specific quantified clinical trial data with sample sizes and numerical outcomes are not available in current literature. The evidence strength remains limited without controlled human studies.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.